KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

Evaluation of previous HLA typing for the Fred Hutchinson Cancer Center Clinical Coordinator Office prior to consult appointments (includes review of CIL and outside lab typing). Review and advice on ...

Fluidigm () today announced an agreement to develop and supply a customized version of its high-throughput library prep system to the DKMS (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft ...

CareDx CDNA recently announced the launch of AlloSeq Nano, a nanopore-based HLA (human leukocyte antigen) and ABO genotyping ...

Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic ...

HLA testing is being used in the field of pharmacogenomics to find the possible drug hypersensitivity reaction. 01 has been identified as a possible marker for abacavir-induced hypersensitivity, and ...

Clinical utility of next-generation sequencing (NGS)-based genomic profiling of advanced solid tumors in routine clinical practice. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I ...

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the forecast period. Market growth is driven by the rising demand for organ and ...

Initial focus on non-diagnostic testing with Next Generation Sequencing (NGS) for infection control, outbreak management and research First commercial orders received and processed Vienna, Austria, ...